Concepedia

Publication | Open Access

Cost-effectiveness of<i>CYP2C19</i>-guided P2Y12 inhibitors in Veterans undergoing percutaneous coronary intervention for acute coronary syndromes

DOIFull Paper Access

11

Citations

18

References

2022

Year

Olivia M Dong, Kevin A. Friede, Catherine Chanfreau‐Coffinier, Deepak Voora
European Heart Journal - Quality of Care and Clinical Outcomes

Abstract

In Veterans post-ACS/PCI, CYP2C19-guided P2Y12 inhibitor selection can improve CV outcomes and lower costs for the VHA within 12 months of implementation.

References

YearCitations

Page 1